Existing Annotations Review

GO Term	Evidence	Action	Reason
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity	IBA GO_REF:0000033	ACCEPT	Summary: This is the defining core molecular function of UGGT1. It transfers a glucose residue from UDP-glucose onto deglucosylated N-linked glycans on non-native glycoproteins, regenerating the monoglucosylated tag of the calnexin/calreticulin cycle. Falcon deep research confirms the reaction and its Ca2+/DxD-motif requirement. Reason: Core molecular function, well supported phylogenetically (IBA), by direct rat biochemistry (PMID:10764828, PMID:1533626), and by the falcon synthesis. Supporting Evidence: file:rat/Uggt1/Uggt1-deep-research-falcon.md UGGT1 is a reglucosylating glycosyltransferase that transfers a glucose residue from UDP-glucose onto deglucosylated N-linked glycans on glycoproteins that have not reached a native conformation. file:rat/Uggt1/Uggt1-deep-research-falcon.md UGGT1 converted Man9GlcNAc2 → Glc1Man9GlcNAc2 on MHC I, which is the canonical “tag” for lectin-chaperone binding in the ER. file:rat/Uggt1/Uggt1-deep-research-falcon.md UGGT1 catalytic activity requires Ca2+, coordinated by a DxD motif in the catalytic site
GO:0005783 endoplasmic reticulum	IBA GO_REF:0000033	ACCEPT	Summary: Manual review: endoplasmic reticulum is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0051082 unfolded protein binding	IBA GO_REF:0000033	ACCEPT	Summary: UGGT1 is a conformation sensor that selectively recognizes and binds non-native/partially folded glycoproteins (preferring exposed hydrophobic surfaces) as the recognition step preceding reglucosylation. This is a genuine core molecular function, not an over-annotation; the falcon synthesis supports it directly and the binding activity is also documented by direct assay (GO:0051082 IDA from PMID:10764828). Reason: Reversed prior over-annotation call. Recognition/binding of non-native glycoprotein clients is the substrate-selection function intrinsic to UGGT1's folding-sensor role, supported by IBA, IDA, and the falcon synthesis. Supporting Evidence: file:rat/Uggt1/Uggt1-deep-research-falcon.md UGGT1 is a conformation sensor: it preferentially acts on proteins that are non-native and can prefer clients with exposed hydrophobic regions, consistent with recognition of misfolded/partially folded surfaces rather than fully folded proteins.
GO:0097359 UDP-glucosylation	IEA GO_REF:0000108	ACCEPT	Summary: Manual review: UDP-glucosylation is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity	IEA GO_REF:0000120	ACCEPT	Summary: Manual review: UDP-glucose:glycoprotein glucosyltransferase activity is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0005788 endoplasmic reticulum lumen	IEA GO_REF:0000044	ACCEPT	Summary: Manual review: endoplasmic reticulum lumen is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0005793 endoplasmic reticulum-Golgi intermediate compartment	IEA GO_REF:0000044	ACCEPT	Summary: Manual review: endoplasmic reticulum-Golgi intermediate compartment is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0009101 glycoprotein biosynthetic process	IEA GO_REF:0000002	KEEP AS NON CORE	Summary: Manual review: glycoprotein biosynthetic process may be context-dependent or peripheral for Uggt1. Reason: Kept as non-core to preserve potentially valid context-specific annotation without elevating it to core function.
GO:0016740 transferase activity	IEA GO_REF:0000043	ACCEPT	Summary: Manual review: transferase activity is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0016757 glycosyltransferase activity	IEA GO_REF:0000043	ACCEPT	Summary: Manual review: glycosyltransferase activity is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:1901135 carbohydrate derivative metabolic process	IEA GO_REF:0000117	KEEP AS NON CORE	Summary: Manual review: carbohydrate derivative metabolic process may be context-dependent or peripheral for Uggt1. Reason: Kept as non-core to preserve potentially valid context-specific annotation without elevating it to core function.
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity	ISO GO_REF:0000121	ACCEPT	Summary: Manual review: UDP-glucose:glycoprotein glucosyltransferase activity is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0009306 protein secretion	ISO GO_REF:0000121	KEEP AS NON CORE	Summary: Manual review: protein secretion may be context-dependent or peripheral for Uggt1. Reason: Kept as non-core to preserve potentially valid context-specific annotation without elevating it to core function.
GO:0032991 protein-containing complex	ISO GO_REF:0000121	KEEP AS NON CORE	Summary: Manual review: protein-containing complex may be context-dependent or peripheral for Uggt1. Reason: Kept as non-core to preserve potentially valid context-specific annotation without elevating it to core function.
GO:0005515 protein binding	IPI PMID:11278576 Association between the 15-kDa selenoprotein and UDP-glucose...	MARK AS OVER ANNOTATED	Summary: This IPI corresponds to the specific UGGT1-SELENOF (SEP15) interaction reported in PMID:11278576. The bare 'protein binding' term is uninformative; the functionally relevant partnership is a stable, high-affinity complex with the redox-active selenoprotein cochaperone SELENOF, documented in the falcon synthesis. The interaction itself is real and biologically meaningful, but GO:0005515 does not capture it. Reason: Bare protein binding is uninformative per curation guidelines. The underlying SELENOF/SEP15 interaction is captured descriptively here rather than by this generic term. Supporting Evidence: file:rat/Uggt1/Uggt1-deep-research-falcon.md UGGT1 forms a stable complex with the selenoprotein SEP15/SELENOF, which is proposed to act as a redox-active cochaperone in ER folding surveillance.
GO:0005788 endoplasmic reticulum lumen	IDA PMID:11535823 Immunolocalization of UDP-glucose:glycoprotein glucosyltrans...	ACCEPT	Summary: UGGT1 is a soluble ER luminal enzyme bearing a C-terminal ER-retention motif; the ER lumen is where it carries out reglucosylation as part of the CNX/CRT quality-control cycle. This is the core site of action, supported by direct immunolocalization (PMID:11535823) and the falcon synthesis. Reason: Core subcellular localization, directly observed (IDA) and consistent with the falcon synthesis describing UGGT1 as an ER-resident luminal enzyme. Supporting Evidence: file:rat/Uggt1/Uggt1-deep-research-falcon.md UGGT1 is described across multiple mammalian studies as ER-localized/ER-resident and operating in the ER lumen as part of ER protein quality control and early secretory pathway surveillance.
GO:0005793 endoplasmic reticulum-Golgi intermediate compartment	IDA PMID:11535823 Immunolocalization of UDP-glucose:glycoprotein glucosyltrans...	ACCEPT	Summary: Manual review: endoplasmic reticulum-Golgi intermediate compartment is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0051082 unfolded protein binding	ISO GO_REF:0000121	ACCEPT	Summary: Same as the IBA/IDA unfolded protein binding annotations - recognition and binding of non-native glycoprotein clients is a core UGGT1 function, not an over-annotation. The ISO transfer from orthologs is consistent with the conserved folding-sensor mechanism described in the falcon synthesis. Reason: Reversed prior over-annotation call to match the IDA-supported core recognition function of UGGT1. Supporting Evidence: file:rat/Uggt1/Uggt1-deep-research-falcon.md UGGT1 preferentially acts on non-native/partially folded glycoproteins and prefers proteins with exposed hydrophobic regions over folded proteins.
GO:0051082 unfolded protein binding	IDA PMID:10764828 Cloning and characterization of mammalian UDP-glucose glycop...	ACCEPT	Summary: Direct-assay evidence that UGGT1 binds non-native protein substrates. Recognition of misfolded/partially folded glycoproteins is the substrate-selection step of the folding-sensor mechanism and is a core molecular function. Reversing the prior over-annotation call; the falcon synthesis corroborates the conformation-sensing recognition activity. Reason: Direct experimental evidence (IDA) for binding of non-native protein clients; this is the core recognition function of UGGT1, not generic protein binding. Supporting Evidence: file:rat/Uggt1/Uggt1-deep-research-falcon.md UGGT1 is a conformation sensor: it preferentially acts on proteins that are non-native and can prefer clients with exposed hydrophobic regions
GO:0005515 protein binding	IPI PMID:10764828 Cloning and characterization of mammalian UDP-glucose glycop...	MARK AS OVER ANNOTATED	Summary: Manual review: protein binding is too generic or over-extended for Uggt1. Reason: Marked over-annotated because more specific terms capture the biology more accurately.
GO:0005783 endoplasmic reticulum	ISO GO_REF:0000121	ACCEPT	Summary: Manual review: endoplasmic reticulum is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity	IDA PMID:10764828 Cloning and characterization of mammalian UDP-glucose glycop...	ACCEPT	Summary: Manual review: UDP-glucose:glycoprotein glucosyltransferase activity is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0051084 'de novo' post-translational protein folding	TAS PMID:10764828 Cloning and characterization of mammalian UDP-glucose glycop...	KEEP AS NON CORE	Summary: Manual review: 'de novo' post-translational protein folding may be context-dependent or peripheral for Uggt1. Reason: Kept as non-core to preserve potentially valid context-specific annotation without elevating it to core function.
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity	TAS PMID:10764828 Cloning and characterization of mammalian UDP-glucose glycop...	ACCEPT	Summary: Manual review: UDP-glucose:glycoprotein glucosyltransferase activity is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0003980 UDP-glucose:glycoprotein glucosyltransferase activity	IDA PMID:12518055 UDP-Glc:glycoprotein glucosyltransferase recognizes structur...	ACCEPT	Summary: Manual review: UDP-glucose:glycoprotein glucosyltransferase activity is consistent with known biology of Uggt1. Reason: Retained as supported or plausible for this gene and evidence context.
GO:0006457 protein folding	TAS PMID:12518055 UDP-Glc:glycoprotein glucosyltransferase recognizes structur...	KEEP AS NON CORE	Summary: UGGT1 contributes to protein folding indirectly, by reglucosylating non-native glycoproteins so they re-engage the calnexin/calreticulin lectin chaperones for additional folding rounds and avoid premature ER exit. The generic 'protein folding' term captures this only at a high level; the precise role is the glycan-dependent quality-control/folding cycle described in the falcon synthesis. Retained as a valid but non-core/broad annotation. Reason: UGGT1 does not directly fold proteins; it drives the lectin-chaperone folding cycle. Kept as non-core because the term is broad relative to the specific reglucosylation/quality-control mechanism. Supporting Evidence: file:rat/Uggt1/Uggt1-deep-research-falcon.md When a glycoprotein carries a monoglucosylated N-glycan it can bind CNX/CRT; after deglucosylation, a protein that is still non-native can be reglucosylated by UGGT1, enabling additional rounds of CNX/CRT-assisted folding and preventing premature ER exit.

Core Functions

ER luminal folding sensor that reglucosylates non-native glycoproteins to regenerate the monoglucosylated N-glycan tag, driving the calnexin/calreticulin quality-control cycle.

Molecular Function:

UDP-glucose:glycoprotein glucosyltransferase activity

Directly Involved In:

protein folding

Cellular Locations:

endoplasmic reticulum lumen

Supporting Evidence:

file:rat/Uggt1/Uggt1-deep-research-falcon.md
UGGT1 is a **reglucosylating glycosyltransferase** that transfers a **glucose residue from UDP-glucose** onto **deglucosylated N-linked glycans** on glycoproteins that have not reached a native conformation.

Conformation-sensing recognition and binding of non-native/partially folded glycoprotein clients (the substrate-selection step preceding reglucosylation).

Molecular Function:

unfolded protein binding

Cellular Locations:

endoplasmic reticulum lumen

Supporting Evidence:

file:rat/Uggt1/Uggt1-deep-research-falcon.md
UGGT1 is a conformation sensor: it preferentially acts on proteins that are **non-native** and can prefer clients with **exposed hydrophobic regions**, consistent with recognition of misfolded/partially folded surfaces rather than fully folded proteins.

References

GO_REF:0000002

Gene Ontology annotation through association of InterPro records with GO terms

GO_REF:0000033

Annotation inferences using phylogenetic trees

GO_REF:0000043

Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping

GO_REF:0000044

Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt

GO_REF:0000108

Automatic assignment of GO terms using logical inference, based on on inter-ontology links

GO_REF:0000117

Electronic Gene Ontology annotations created by ARBA machine learning models

GO_REF:0000120

Combined Automated Annotation using Multiple IEA Methods

GO_REF:0000121

RGD ISO annotations to rat from other mammalian species

PMID:10764828

Cloning and characterization of mammalian UDP-glucose glycoprotein: glucosyltransferase and the development of a specific substrate for this enzyme.

PMID:11278576

Association between the 15-kDa selenoprotein and UDP-glucose:glycoprotein glucosyltransferase in the endoplasmic reticulum of mammalian cells.

PMID:11535823

Immunolocalization of UDP-glucose:glycoprotein glucosyltransferase indicates involvement of pre-Golgi intermediates in protein quality control.

PMID:12518055

UDP-Glc:glycoprotein glucosyltransferase recognizes structured and solvent accessible hydrophobic patches in molten globule-like folding intermediates.

file:rat/Uggt1/Uggt1-deep-research-falcon.md

Falcon (Edison Scientific) deep research report: Functional Annotation of Rat Uggt1 (UGGT1; UniProt Q9JLA3)

UGGT1 is an ER luminal glycoprotein-folding sensor that reglucosylates N-linked glycans on non-native glycoproteins, acting as the central quality-control enzyme of the calnexin/calreticulin cycle.

"a ~170 kDa **endoplasmic reticulum (ER) luminal** glycoprotein-folding sensor and quality-control enzyme that catalyzes reglucosylation of N-linked glycans on non-native glycoproteins."
UGGT1 transfers glucose from UDP-glucose onto deglucosylated N-glycans, converting Man9GlcNAc2 to Glc1Man9GlcNAc2, the tag recognized by lectin chaperones.

"UGGT1 converted **Man9GlcNAc2 → Glc1Man9GlcNAc2** on MHC I, which is the canonical “tag” for lectin-chaperone binding in the ER."
Catalysis requires Ca2+ coordinated by a DxD motif in the catalytic site.

"UGGT1 catalytic activity requires **Ca2+**, coordinated by a **DxD motif** in the catalytic site"
UGGT1 is a conformation sensor that preferentially recognizes non-native glycoproteins with exposed hydrophobic regions.

"UGGT1 is a conformation sensor: it preferentially acts on proteins that are **non-native** and can prefer clients with **exposed hydrophobic regions**, consistent with recognition of misfolded/partially folded surfaces rather than fully folded proteins."
UGGT1 functions within the calnexin/calreticulin (CNX/CRT) cycle, reglucosylating misfolded glycoproteins so they rebind lectin chaperones and avoid premature ER exit.

"UGGT1’s primary pathway role is within the **N-glycan-dependent lectin chaperone system** (CNX/CRT cycle) that retains and refolds non-native glycoproteins."
UGGT1-mediated reglucosylation can delay entry into glycoprotein ERAD, competing with EDEM/mannose-trimming degradation pathways in a tug-of-war over glycoprotein fate.

"UGGT1-mediated reglucosylation can **delay entry into gpERAD**, competing with EDEM/mannose trimming that promotes degradation."
UGGT1 is the dominant cellular glucosyltransferase of this system and shows preference toward large plasma-membrane proteins.

"UGGT1 was the **dominant** cellular glucosyltransferase in that study and showed preference toward **large plasma-membrane proteins**, while UGGT2 favored smaller soluble lysosomal proteins"
UGGT1 forms a stable complex with the selenoprotein SELENOF (SEP15), a proposed redox-active cochaperone.

"UGGT1 forms a stable complex with the selenoprotein **SEP15/SELENOF**, which is proposed to act as a **redox-active cochaperone** in ER folding surveillance."
UGGT1 is an ER-resident luminal enzyme of the early secretory pathway.

"UGGT1 is described across multiple mammalian studies as **ER-localized/ER-resident** and operating in the **ER lumen** as part of ER protein quality control and early secretory pathway surveillance."
UGGT1 is widely conceptualized as an ER gatekeeper / folding sensor that enforces quality control of the secretory proteome via glycan reglucosylation.

"UGGT1 is widely conceptualized as an ER “**gatekeeper**” or “folding sensor” that enforces quality control of the secretory proteome via glycan reglucosylation"

Suggested Experiments

Experiment: Measure rat UGGT1 reglucosylation activity on defined non-native glycoprotein substrates (e.g. M9-BODIPY) in liver ER fractions with and without Ca2+ chelation and DxD-motif mutation, to dissociate client binding from catalysis.

Experiment: Use SELENOF/SEP15 knockdown in a rat hepatocyte model to test whether loss of the cochaperone alters the set of glycoproteins reglucosylated by UGGT1 and shifts client fate toward gpERAD.

Deep Research

Falcon

(Uggt1-deep-research-falcon.md)

this with annotations you find in gene/protein databases, but these can be outdated or inaccurate. Falcon Edison Scientific Literature 28 citations 1 artifacts 2026-06-01T03:19:07.038082

Edison artifact artifact-00 (text/markdown)

The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.

You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.

We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.

We are interested in where in or outside the cell the gene product carries out its function.

We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.

Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.

Research Report: Functional Annotation of Rat Uggt1 (UGGT1; UniProt Q9JLA3)

1. Target verification and gene/protein identity (critical disambiguation)

Uggt1 (UniProt Q9JLA3) in Rattus norvegicus encodes UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1), a ~170 kDa endoplasmic reticulum (ER) luminal glycoprotein-folding sensor and quality-control enzyme that catalyzes reglucosylation of N-linked glycans on non-native glycoproteins. This function places Uggt1 in the ER glycoprotein folding/quality-control system (the calnexin/calreticulin cycle) and distinguishes it from (i) drug-metabolizing “UGT1A” glucuronosyltransferases and (ii) the paralog UGGT2, which has overlapping but distinct client preferences and lower abundance in some systems. (sagert2023theerfolding pages 1-2, adams2020quantitativeglycoproteomicsreveals pages 1-4, ninagawa2024uggt1mediatedreglucosylationof pages 5-9)

2. Key concepts and definitions (current understanding)

2.1. What reaction does UGGT1 catalyze?

UGGT1 is a reglucosylating glycosyltransferase that transfers a glucose residue from UDP-glucose onto deglucosylated N-linked glycans on glycoproteins that have not reached a native conformation. In a defined antigen-presentation substrate system, UGGT1 converted Man9GlcNAc2 → Glc1Man9GlcNAc2 on MHC I, which is the canonical “tag” for lectin-chaperone binding in the ER. (sagert2023theerfolding pages 1-2, sagert2023theerfolding pages 7-8)

Catalytic requirements: UGGT1 catalytic activity requires Ca2+, coordinated by a DxD motif in the catalytic site; importantly, Ca2+ is necessary for catalysis but not necessarily for client binding in all contexts (see §3.1). (sagert2023theerfolding pages 7-8)

2.2. What is the “calnexin/calreticulin cycle” and UGGT1’s role?

The calnexin (CNX) / calreticulin (CRT) cycle is an ER lectin-chaperone system for folding N-glycosylated proteins. When a glycoprotein carries a monoglucosylated N-glycan it can bind CNX/CRT; after deglucosylation, a protein that is still non-native can be reglucosylated by UGGT1, enabling additional rounds of CNX/CRT-assisted folding and preventing premature ER exit. (ninagawa2024uggt1mediatedreglucosylationof pages 1-5, sagert2023theerfolding pages 1-2)

2.3. Substrate specificity (“folding sensor” concept)

UGGT1 is a conformation sensor: it preferentially acts on proteins that are non-native and can prefer clients with exposed hydrophobic regions, consistent with recognition of misfolded/partially folded surfaces rather than fully folded proteins. (ninagawa2024uggt1mediatedreglucosylationof pages 1-5, ninagawa2024uggt1mediatedreglucosylationof pages 5-9)

A quantitative glycoproteomics strategy identified 71 endogenous UGGT substrates (in human cell models) and found these clients are biased toward large, multidomain, heavily glycosylated proteins. UGGT1 was the dominant cellular glucosyltransferase in that study and showed preference toward large plasma-membrane proteins, while UGGT2 favored smaller soluble lysosomal proteins. (adams2020quantitativeglycoproteomicsreveals pages 1-4)

3. Recent developments and latest research (prioritizing 2023–2024)

3.1. 2023: UGGT1 cooperates with TAPBPR to enforce MHC I quality control

A 2023 eLife study reconstituted an in vitro system with purified human proteins and used glycoengineering plus LC–MS to measure UGGT1 activity on MHC I. The work showed that the MHC I chaperone TAPBPR promotes UGGT1-catalyzed reglucosylation of peptide-free MHC I, while high-affinity peptide-loaded MHC I was not glucosylated—supporting a model where UGGT1 edits/folds only non-native states. (Publication: Jan 2023; https://doi.org/10.7554/eLife.85432) (sagert2023theerfolding pages 1-2, sagert2023theerfolding pages 8-9)

Quantitative data: Under their assay conditions, the UGGT1 reaction on the MHC I substrate reached a saturation of ~80%. (sagert2023theerfolding pages 8-9)

Mechanistic refinement (binding vs catalysis): Ca2+ is essential for UGGT1 catalysis, but in pull-down experiments, chelation (EGTA) or a catalytic-site mutant did not reduce binding of UGGT1 to the TAPBPR-associated MHC I complex, indicating that binding determinants can be separable from catalytic metal dependence. (sagert2023theerfolding pages 7-8)

3.2. 2024: UGGT1 activity competes with ERAD (“tug-of-war” model) and impacts ATF6α signaling

A 2024 eLife study (preprint in 2023) directly tested the long-standing question of whether reglucosylation affects degradation of unstable/misfolded glycoproteins by using genetically disrupted UGGT1/UGGT2 cells. It reported that UGGT1 delays degradation of several misfolded/unstable substrates and framed glycoprotein fate as a “tug-of-war” between UGGT1-driven structure formation (via CNX/CRT re-entry) and degradation driven by mannose trimming/EDEM-mediated pathways. (Publication: Sep 2024; https://doi.org/10.1101/2023.10.18.562958) (ninagawa2024uggt1mediatedreglucosylationof pages 12-16, ninagawa2024uggt1mediatedreglucosylationof pages 1-5)

Pathway-level consequence: The authors further report physiological importance for ER stress signaling, stating ATF6α cannot function properly without UGGTs (UGGT1/2), with reduced induction of ERSE/UPRE reporters in UGGT-deficient contexts while ATF4 reporter activity was unchanged. (ninagawa2024uggt1mediatedreglucosylationof pages 12-16)

Quantitative/statistical notes from the study excerpt: UGGT2 protein abundance was reported as ~6.9% of UGGT1 in HCT116 cells and 29.8% of UGGT1 in HeLa cells, supporting UGGT1 as the dominant paralog in some mammalian systems. (ninagawa2024uggt1mediatedreglucosylationof pages 5-9)

3.3. 2024: Structural/mechanistic insight into the UGGT1–SEP15 (SELENOF) cochaperone complex

UGGT1 forms a stable complex with the selenoprotein SEP15/SELENOF, which is proposed to act as a redox-active cochaperone in ER folding surveillance.

A 2024 PNAS study used AlphaFold2/AlphaFold-multimer plus mutagenesis and co-immunoprecipitation to refine the UGGT1–SEP15 interface. It proposed a UGGT1 SEP15-binding region (SBR) (a helix–loop–helix insertion) that is present in organisms with SEP15 and absent in organisms lacking SEP15, and it predicted a complex interface with buried surface area of about 1,860 Å². (Publication: Aug 12, 2024; https://doi.org/10.1073/pnas.2315009121) (williams2024insightsintothe pages 3-4, williams2024insightsintothe pages 1-2)

Experimental validation (quantitative): In cell co-IP experiments summarized in the excerpt, WT interaction was measurable (reported as ~27% of expressed SEP15 detected in complex in that experimental configuration), while UGGT1 interface point mutants sharply reduced binding to ~3.8% and ~6.5%, supporting the model-predicted interface. (williams2024insightsintothe pages 5-6)

Earlier authoritative synthesis: A widely cited 2020 FEBS Journal review reported a high-affinity UGGT1–Sep15 interaction with Kd ≈ 20 nM, and that essentially the entire cellular pool of Sep15 may be UGGT1-bound (whereas UGGT1 can exist both bound and free). (Publication: Apr 2020; https://doi.org/10.1111/febs.15330) (kozlov2020calnexincycle– pages 12-14)

4. Cellular localization and pathways

4.1. Subcellular localization

UGGT1 is described across multiple mammalian studies as ER-localized/ER-resident and operating in the ER lumen as part of ER protein quality control and early secretory pathway surveillance. (sagert2023theerfolding pages 1-2, ninagawa2024uggt1mediatedreglucosylationof pages 5-9)

4.2. Primary pathway membership and network context

UGGT1’s primary pathway role is within the N-glycan-dependent lectin chaperone system (CNX/CRT cycle) that retains and refolds non-native glycoproteins. (ninagawa2024uggt1mediatedreglucosylationof pages 1-5, sagert2023theerfolding pages 1-2)

Recent evidence expands UGGT1’s functional position to a decision layer that can antagonize premature degradation: UGGT1-mediated reglucosylation can delay entry into gpERAD, competing with EDEM/mannose trimming that promotes degradation. (ninagawa2024uggt1mediatedreglucosylationof pages 12-16, ninagawa2024uggt1mediatedreglucosylationof pages 5-9)

5. Rat-specific evidence (Rattus norvegicus) for Uggt1 regulation and function

Direct mechanistic studies are largely performed in human or other mammalian cell systems, but there is experimentally grounded rat evidence for Uggt1/UGGT1 regulation at the mRNA/protein/activity levels in metabolic disease models.

A 2020 FEBS Letters study quantified UGGT1 in liver ER fractions from Zucker rat models:
- Zucker fatty (ZF) obesity vs lean controls (ZN): Uggt1 mRNA ~0.6-fold, UGGT1 protein ~0.6-fold, and UGGT1 enzymatic activity was reported as ~60% lower. (Publication: Apr 2020; https://doi.org/10.1002/1873-3468.13780) (kuribara2020metabolicsyndromeperturbs pages 5-7)
- Zucker diabetic fatty (ZDF) obese type 2 diabetes vs obese (ZF): Uggt1 mRNA ~1.7-fold higher and UGGT1 protein ~1.5-fold higher, yet enzymatic activity was ~0.5-fold compared with ZF, showing a marked abundance–activity mismatch under severe metabolic syndrome. (kuribara2020metabolicsyndromeperturbs pages 7-9, kuribara2020metabolicsyndromeperturbs pages 9-10)

Methods and rigor notes: The study measured UGGT1 activity using a fluorescent glycan substrate (M9-BODIPY) and quantified products by HPLC/fluorescence in solubilized liver ER fractions; mRNA was assayed by qPCR with β2-microglobulin normalization and protein by western blot with β-actin loading control. Reported data were mean ± SD (n=3). (kuribara2020metabolicsyndromeperturbs pages 2-5, kuribara2020metabolicsyndromeperturbs pages 7-9)

6. Current applications and real-world implementations

Antigen presentation quality control: The 2023 reconstitution study demonstrates a concrete immunology application: UGGT1 can be functionally integrated with MHC I peptide editing via TAPBPR, refining how antigen-presenting cells enforce quality control on peptide-receptive MHC I before export. (sagert2023theerfolding pages 8-9, sagert2023theerfolding pages 1-2)
ER proteostasis engineering and glycoprotein manufacturing relevance (mechanism-to-implementation): Quantitative mapping of UGGT1 client selectivity (71 endogenous substrates) and discovery that UGGT1 can antagonize early ERAD provide actionable principles for engineering secretion or stability of difficult-to-fold glycoproteins (e.g., choosing interventions that modulate reglucosylation vs mannose trimming). These represent enabling findings for biotechnology even when not yet deployed as standardized industrial protocols. (adams2020quantitativeglycoproteomicsreveals pages 1-4, ninagawa2024uggt1mediatedreglucosylationof pages 12-16)
Disease-model interpretation and biomolecular phenotyping: Rat metabolic syndrome models show that UGGT1 activity can be strongly decreased even when expression is increased, emphasizing that activity assays (not only transcript/protein quantification) are required to interpret ER quality control capacity in vivo. (kuribara2020metabolicsyndromeperturbs pages 7-9, kuribara2020metabolicsyndromeperturbs pages 5-7)

7. Expert opinion and authoritative synthesis (with grounded interpretation)

UGGT1 is widely conceptualized as an ER “gatekeeper” or “folding sensor” that enforces quality control of the secretory proteome via glycan reglucosylation, with SEP15 serving as a redox-active partner. This framing is reinforced by: (i) experimental reconstitution in 2023 demonstrating chaperone-dependent client processing (TAPBPR/MHC I), (ii) 2024 genetic evidence that UGGT1 actively competes with gpERAD rather than acting only as a passive “safety net,” and (iii) 2024 structure-guided mapping of the UGGT1–SEP15 interface with quantitative mutational disruption. (sagert2023theerfolding pages 1-2, ninagawa2024uggt1mediatedreglucosylationof pages 12-16, williams2024insightsintothe pages 1-2, williams2024insightsintothe pages 5-6)

8. Summary of key evidence (quick reference)

The following table compiles the principal functional annotation points and quantitative findings from the evidence base used here:

Aspect	Key details	Key sources (with year, venue)	URL
Identity	Target verified as rat Uggt1/UGGT1 (UniProt Q9JLA3), the mammalian UDP-glucose:glycoprotein glucosyltransferase 1, an ER quality-control glucosyltransferase distinct from drug-metabolizing UGT1A enzymes, UGGT2, or ceramide glucosyltransferase. It is described as a central ER folding sensor/gatekeeper for N-glycosylated proteins (sagert2023theerfolding pages 1-2, adams2020quantitativeglycoproteomicsreveals pages 1-4).	Sagert et al., 2023, eLife; Adams et al., 2020, eLife	https://doi.org/10.7554/elife.85432 ; https://doi.org/10.7554/elife.63997
Reaction	UGGT1 catalyzes reglucosylation: transfer of glucose from UDP-glucose onto deglucosylated N-linked glycans, e.g. conversion of Man9GlcNAc2 to Glc1Man9GlcNAc2 on non-native glycoproteins; catalytic activity requires Ca2+ coordinated by a DxD motif (sagert2023theerfolding pages 1-2, sagert2023theerfolding pages 7-8).	Sagert et al., 2023, eLife	https://doi.org/10.7554/elife.85432
Substrate specificity	UGGT1 preferentially acts on non-native/partially folded glycoproteins and prefers proteins with exposed hydrophobic regions over folded proteins. Cellular substrates are enriched for large, multidomain, heavily glycosylated proteins; UGGT1 is the dominant mammalian glucosyltransferase and shows preference toward large plasma-membrane proteins (ninagawa2024uggt1mediatedreglucosylationof pages 1-5, adams2020quantitativeglycoproteomicsreveals pages 1-4, adams2020quantitativeglycoproteomicsreveals pages 4-7).	Ninagawa et al., 2024, eLife; Adams et al., 2020, eLife	https://doi.org/10.1101/2023.10.18.562958 ; https://doi.org/10.7554/elife.63997
Localization	UGGT1 is an ER-resident/ER-localized luminal enzyme in the early secretory pathway; both mammalian UGGT1 and UGGT2 are described as ER-localized glycoproteins with Endo H-sensitive N-glycans (ninagawa2024uggt1mediatedreglucosylationof pages 5-9, sagert2023theerfolding pages 1-2).	Ninagawa et al., 2024, eLife; Sagert et al., 2023, eLife	https://doi.org/10.1101/2023.10.18.562958 ; https://doi.org/10.7554/elife.85432
Pathway role	UGGT1 functions in the calnexin/calreticulin (CNX/CRT) cycle, re-glucosylating misfolded glycoproteins so they can rebind lectin chaperones and avoid premature ER exit. Newer evidence indicates UGGT1 also delays glycoprotein ER-associated degradation (gpERAD), creating a “tug-of-war” between refolding and EDEM/mannose-trimming-driven degradation; proper ATF6α function depends on UGGT activity (ninagawa2024uggt1mediatedreglucosylationof pages 12-16, ninagawa2024uggt1mediatedreglucosylationof pages 1-5, ninagawa2024uggt1mediatedreglucosylationof pages 5-9, sagert2023theerfolding pages 1-2).	Ninagawa et al., 2024, eLife; Sagert et al., 2023, eLife	https://doi.org/10.1101/2023.10.18.562958 ; https://doi.org/10.7554/elife.85432
Binding partners	Supported partners include TAPBPR, which promotes UGGT1-mediated reglucosylation of peptide-free MHC I, and SEP15/SELENOF, a redox-active selenoprotein that forms a stable complex with UGGT1. SEP15 binding maps largely to its N-terminal cysteine-rich domain (CRD) and a predicted SEP15-binding region (SBR) in UGGT1; prior review evidence cites high-affinity binding (Kd ~20 nM) (sagert2023theerfolding pages 8-9, williams2024insightsintothe pages 3-4, williams2024insightsintothe pages 2-3, williams2024insightsintothe pages 1-2, kozlov2020calnexincycle– pages 12-14).	Sagert et al., 2023, eLife; Williams et al., 2024, PNAS; Kozlov & Gehring, 2020, FEBS J.	https://doi.org/10.7554/elife.85432 ; https://doi.org/10.1073/pnas.2315009121 ; https://doi.org/10.1111/febs.15330
Recent 2023-2024 developments	2023: Reconstituted human-protein system showed TAPBPR is an essential mediator for UGGT1 reglucosylation of peptide-free MHC I in at least some allomorphs; UGGT1-catalyzed conversion reached about 80% saturation in the assay, and Ca2+ was required for catalysis but not for binding to the MHC I–TAPBPR complex (sagert2023theerfolding pages 8-9, sagert2023theerfolding pages 7-8). 2024: UGGT1 was shown to compete with ERAD and inhibit early degradation of unstable/misfolded glycoproteins, including ATF6α (ninagawa2024uggt1mediatedreglucosylationof pages 12-16, ninagawa2024uggt1mediatedreglucosylationof pages 5-9). 2024: AlphaFold2 plus mutagenesis/co-IP refined the UGGT1–SEP15 interface, identifying an interface of about 1,860 Å2 and validating UGGT1 interface mutants that strongly reduced SEP15 binding (williams2024insightsintothe pages 3-4, williams2024insightsintothe pages 5-6, williams2024insightsintothe pages 4-5).	Sagert et al., 2023, eLife; Ninagawa et al., 2024, eLife; Williams et al., 2024, PNAS	https://doi.org/10.7554/elife.85432 ; https://doi.org/10.1101/2023.10.18.562958 ; https://doi.org/10.1073/pnas.2315009121
Rat-specific findings	Direct rat evidence is limited but present in rat liver metabolic-disease models. In Zucker fatty rats, Uggt1 mRNA, UGGT1 protein, and UGGT1 enzymatic activity are all reduced versus lean controls; in Zucker diabetic fatty rats, mRNA/protein rise relative to obese rats but enzymatic activity remains impaired, indicating discordance between abundance and function under severe metabolic stress (kuribara2020metabolicsyndromeperturbs pages 5-7, kuribara2020metabolicsyndromeperturbs pages 9-10, kuribara2020metabolicsyndromeperturbs pages 7-9, kuribara2020metabolicsyndromeperturbs pages 1-2).	Kuribara et al., 2020, FEBS Letters	https://doi.org/10.1002/1873-3468.13780
Quantitative stats	Quantitative values supported by evidence include: 71 endogenous UGGT substrates identified in human cells, with a conservative 3-fold enrichment cutoff for high-confidence substrates (adams2020quantitativeglycoproteomicsreveals pages 1-4, adams2020quantitativeglycoproteomicsreveals pages 4-7); UGGT2 abundance was about 6.9% of UGGT1 in HCT116 cells and 29.8% in HeLa cells (ninagawa2024uggt1mediatedreglucosylationof pages 5-9); in the TAPBPR/MHC I system, UGGT1 reaction saturated at about 80% (sagert2023theerfolding pages 8-9); the UGGT1–SEP15 predicted interface buries about 1,860 Å2, and SEP15 co-IP with WT UGGT1 was about 27%, falling to about 3.8% or 6.5% with UGGT1 interface mutants; SELENOF knockout altered glucosylation of 26 proteins, 7 by at least 50% (williams2024insightsintothe pages 3-4, williams2024insightsintothe pages 5-6, williams2024insightsintothe pages 4-5); in rat ZF liver, Uggt1 mRNA and protein were each about 0.6-fold of lean controls and activity was about 60% lower; in ZDF versus ZF, mRNA was 1.7-fold higher and protein about 1.5-fold higher, yet activity was about 0.5-fold (kuribara2020metabolicsyndromeperturbs pages 5-7, kuribara2020metabolicsyndromeperturbs pages 7-9).	Adams et al., 2020, eLife; Sagert et al., 2023, eLife; Williams et al., 2024, PNAS; Kuribara et al., 2020, FEBS Letters	https://doi.org/10.7554/elife.63997 ; https://doi.org/10.7554/elife.85432 ; https://doi.org/10.1073/pnas.2315009121 ; https://doi.org/10.1002/1873-3468.13780
Applications	Current applications are mainly mechanistic and translational rather than clinical: UGGT1 knowledge is being used to understand antigen presentation quality control (MHC I/TAPBPR), to map ER proteostasis and client selectivity, and to interpret how altered UGGT1 activity affects glycoprotein maturation and metabolic disease-associated ER quality control. These studies also support proteostasis-oriented strategies in biotechnology and disease models, but no direct rat-specific therapeutic implementation was supported in the gathered snippets (sagert2023theerfolding pages 8-9, ninagawa2024uggt1mediatedreglucosylationof pages 12-16, adams2020quantitativeglycoproteomicsreveals pages 1-4, kuribara2020metabolicsyndromeperturbs pages 5-7).	Sagert et al., 2023, eLife; Ninagawa et al., 2024, eLife; Adams et al., 2020, eLife; Kuribara et al., 2020, FEBS Letters	https://doi.org/10.7554/elife.85432 ; https://doi.org/10.1101/2023.10.18.562958 ; https://doi.org/10.7554/elife.63997 ; https://doi.org/10.1002/1873-3468.13780

Table: This table summarizes the supported functional annotation of rat Uggt1/UGGT1 (UniProt Q9JLA3), including biochemical function, ER quality-control role, binding partners, recent mechanistic advances, and rat-specific metabolic-disease evidence. It is useful as a compact evidence map before writing the full narrative report.

9. Limitations of the current evidence base for rat Uggt1

While rat-specific functional enzymology and regulation are available in liver metabolic disease models, most high-resolution mechanistic studies (client structural states, detailed glycan-product mapping, and interaction-interface mapping) are performed in human or other mammalian systems and are used here as strong, but not exclusively rat-derived, evidence for the conserved function of rat Uggt1/UGGT1. (kuribara2020metabolicsyndromeperturbs pages 5-7, sagert2023theerfolding pages 8-9, williams2024insightsintothe pages 5-6)

References

(sagert2023theerfolding pages 1-2): Lina Sagert, Christian Winter, Ina Ruppert, Maximilian Zehetmaier, Christoph Thomas, and Robert Tampé. The er folding sensor uggt1 acts on tapbpr-chaperoned peptide-free mhc i. eLife, Jan 2023. URL: https://doi.org/10.7554/elife.85432, doi:10.7554/elife.85432. This article has 8 citations and is from a domain leading peer-reviewed journal.
(adams2020quantitativeglycoproteomicsreveals pages 1-4): Benjamin M Adams, Nathan P Canniff, Kevin P Guay, Ida Signe Bohse Larsen, and Daniel N Hebert. Quantitative glycoproteomics reveals cellular substrate selectivity of the er protein quality control sensors uggt1 and uggt2. Dec 2020. URL: https://doi.org/10.7554/elife.63997, doi:10.7554/elife.63997. This article has 70 citations and is from a domain leading peer-reviewed journal.
(ninagawa2024uggt1mediatedreglucosylationof pages 5-9): Satoshi Ninagawa, Masaki Matsuo, Deng Ying, Shuichiro Oshita, Shinya Aso, Kazutoshi Matsushita, Mai Taniguchi, Akane Fueki, Moe Yamashiro, Kaoru Sugasawa, Shunsuke Saito, Koshi Imami, Yasuhiko Kizuka, Tetsushi Sakuma, Takashi Yamamoto, Hirokazu Yagi, Koichi Kato, and Kazutoshi Mori. Uggt1-mediated reglucosylation of n-glycan competes with er-associated degradation of unstable and misfolded glycoproteins. eLife, Sep 2024. URL: https://doi.org/10.1101/2023.10.18.562958, doi:10.1101/2023.10.18.562958. This article has 7 citations and is from a domain leading peer-reviewed journal.
(sagert2023theerfolding pages 7-8): Lina Sagert, Christian Winter, Ina Ruppert, Maximilian Zehetmaier, Christoph Thomas, and Robert Tampé. The er folding sensor uggt1 acts on tapbpr-chaperoned peptide-free mhc i. eLife, Jan 2023. URL: https://doi.org/10.7554/elife.85432, doi:10.7554/elife.85432. This article has 8 citations and is from a domain leading peer-reviewed journal.
(ninagawa2024uggt1mediatedreglucosylationof pages 1-5): Satoshi Ninagawa, Masaki Matsuo, Deng Ying, Shuichiro Oshita, Shinya Aso, Kazutoshi Matsushita, Mai Taniguchi, Akane Fueki, Moe Yamashiro, Kaoru Sugasawa, Shunsuke Saito, Koshi Imami, Yasuhiko Kizuka, Tetsushi Sakuma, Takashi Yamamoto, Hirokazu Yagi, Koichi Kato, and Kazutoshi Mori. Uggt1-mediated reglucosylation of n-glycan competes with er-associated degradation of unstable and misfolded glycoproteins. eLife, Sep 2024. URL: https://doi.org/10.1101/2023.10.18.562958, doi:10.1101/2023.10.18.562958. This article has 7 citations and is from a domain leading peer-reviewed journal.
(sagert2023theerfolding pages 8-9): Lina Sagert, Christian Winter, Ina Ruppert, Maximilian Zehetmaier, Christoph Thomas, and Robert Tampé. The er folding sensor uggt1 acts on tapbpr-chaperoned peptide-free mhc i. eLife, Jan 2023. URL: https://doi.org/10.7554/elife.85432, doi:10.7554/elife.85432. This article has 8 citations and is from a domain leading peer-reviewed journal.
(ninagawa2024uggt1mediatedreglucosylationof pages 12-16): Satoshi Ninagawa, Masaki Matsuo, Deng Ying, Shuichiro Oshita, Shinya Aso, Kazutoshi Matsushita, Mai Taniguchi, Akane Fueki, Moe Yamashiro, Kaoru Sugasawa, Shunsuke Saito, Koshi Imami, Yasuhiko Kizuka, Tetsushi Sakuma, Takashi Yamamoto, Hirokazu Yagi, Koichi Kato, and Kazutoshi Mori. Uggt1-mediated reglucosylation of n-glycan competes with er-associated degradation of unstable and misfolded glycoproteins. eLife, Sep 2024. URL: https://doi.org/10.1101/2023.10.18.562958, doi:10.1101/2023.10.18.562958. This article has 7 citations and is from a domain leading peer-reviewed journal.
(williams2024insightsintothe pages 3-4): Robert V. Williams, Kevin P. Guay, Owen A. Hurlbut Lesk, Eugenia M. Clerico, Daniel N. Hebert, and Lila M. Gierasch. Insights into the interaction between uggt, the gatekeeper of folding in the er, and its partner, the selenoprotein sep15. Proceedings of the National Academy of Sciences of the United States of America, Aug 2024. URL: https://doi.org/10.1073/pnas.2315009121, doi:10.1073/pnas.2315009121. This article has 11 citations and is from a highest quality peer-reviewed journal.
(williams2024insightsintothe pages 1-2): Robert V. Williams, Kevin P. Guay, Owen A. Hurlbut Lesk, Eugenia M. Clerico, Daniel N. Hebert, and Lila M. Gierasch. Insights into the interaction between uggt, the gatekeeper of folding in the er, and its partner, the selenoprotein sep15. Proceedings of the National Academy of Sciences of the United States of America, Aug 2024. URL: https://doi.org/10.1073/pnas.2315009121, doi:10.1073/pnas.2315009121. This article has 11 citations and is from a highest quality peer-reviewed journal.
(williams2024insightsintothe pages 5-6): Robert V. Williams, Kevin P. Guay, Owen A. Hurlbut Lesk, Eugenia M. Clerico, Daniel N. Hebert, and Lila M. Gierasch. Insights into the interaction between uggt, the gatekeeper of folding in the er, and its partner, the selenoprotein sep15. Proceedings of the National Academy of Sciences of the United States of America, Aug 2024. URL: https://doi.org/10.1073/pnas.2315009121, doi:10.1073/pnas.2315009121. This article has 11 citations and is from a highest quality peer-reviewed journal.
(kozlov2020calnexincycle– pages 12-14): Guennadi Kozlov and Kalle Gehring. Calnexin cycle – structural features of the er chaperone system. The FEBS Journal, 287:4322-4340, Apr 2020. URL: https://doi.org/10.1111/febs.15330, doi:10.1111/febs.15330. This article has 233 citations.
(kuribara2020metabolicsyndromeperturbs pages 5-7): Taiki Kuribara, Ayami Imagawa, Makoto Hirano, Yukishige Ito, and Kiichiro Totani. Metabolic syndrome perturbs deglucosylation and reglucosylation in the glycoprotein folding cycle. FEBS Letters, 594:1759-1769, Apr 2020. URL: https://doi.org/10.1002/1873-3468.13780, doi:10.1002/1873-3468.13780. This article has 11 citations and is from a peer-reviewed journal.
(kuribara2020metabolicsyndromeperturbs pages 7-9): Taiki Kuribara, Ayami Imagawa, Makoto Hirano, Yukishige Ito, and Kiichiro Totani. Metabolic syndrome perturbs deglucosylation and reglucosylation in the glycoprotein folding cycle. FEBS Letters, 594:1759-1769, Apr 2020. URL: https://doi.org/10.1002/1873-3468.13780, doi:10.1002/1873-3468.13780. This article has 11 citations and is from a peer-reviewed journal.
(kuribara2020metabolicsyndromeperturbs pages 9-10): Taiki Kuribara, Ayami Imagawa, Makoto Hirano, Yukishige Ito, and Kiichiro Totani. Metabolic syndrome perturbs deglucosylation and reglucosylation in the glycoprotein folding cycle. FEBS Letters, 594:1759-1769, Apr 2020. URL: https://doi.org/10.1002/1873-3468.13780, doi:10.1002/1873-3468.13780. This article has 11 citations and is from a peer-reviewed journal.
(kuribara2020metabolicsyndromeperturbs pages 2-5): Taiki Kuribara, Ayami Imagawa, Makoto Hirano, Yukishige Ito, and Kiichiro Totani. Metabolic syndrome perturbs deglucosylation and reglucosylation in the glycoprotein folding cycle. FEBS Letters, 594:1759-1769, Apr 2020. URL: https://doi.org/10.1002/1873-3468.13780, doi:10.1002/1873-3468.13780. This article has 11 citations and is from a peer-reviewed journal.
(adams2020quantitativeglycoproteomicsreveals pages 4-7): Benjamin M Adams, Nathan P Canniff, Kevin P Guay, Ida Signe Bohse Larsen, and Daniel N Hebert. Quantitative glycoproteomics reveals cellular substrate selectivity of the er protein quality control sensors uggt1 and uggt2. Dec 2020. URL: https://doi.org/10.7554/elife.63997, doi:10.7554/elife.63997. This article has 70 citations and is from a domain leading peer-reviewed journal.
(williams2024insightsintothe pages 2-3): Robert V. Williams, Kevin P. Guay, Owen A. Hurlbut Lesk, Eugenia M. Clerico, Daniel N. Hebert, and Lila M. Gierasch. Insights into the interaction between uggt, the gatekeeper of folding in the er, and its partner, the selenoprotein sep15. Proceedings of the National Academy of Sciences of the United States of America, Aug 2024. URL: https://doi.org/10.1073/pnas.2315009121, doi:10.1073/pnas.2315009121. This article has 11 citations and is from a highest quality peer-reviewed journal.
(williams2024insightsintothe pages 4-5): Robert V. Williams, Kevin P. Guay, Owen A. Hurlbut Lesk, Eugenia M. Clerico, Daniel N. Hebert, and Lila M. Gierasch. Insights into the interaction between uggt, the gatekeeper of folding in the er, and its partner, the selenoprotein sep15. Proceedings of the National Academy of Sciences of the United States of America, Aug 2024. URL: https://doi.org/10.1073/pnas.2315009121, doi:10.1073/pnas.2315009121. This article has 11 citations and is from a highest quality peer-reviewed journal.
(kuribara2020metabolicsyndromeperturbs pages 1-2): Taiki Kuribara, Ayami Imagawa, Makoto Hirano, Yukishige Ito, and Kiichiro Totani. Metabolic syndrome perturbs deglucosylation and reglucosylation in the glycoprotein folding cycle. FEBS Letters, 594:1759-1769, Apr 2020. URL: https://doi.org/10.1002/1873-3468.13780, doi:10.1002/1873-3468.13780. This article has 11 citations and is from a peer-reviewed journal.

Artifacts

Edison artifact artifact-00

Citations

sagert2023theerfolding pages 7-8
adams2020quantitativeglycoproteomicsreveals pages 1-4
sagert2023theerfolding pages 8-9
williams2024insightsintothe pages 5-6
kuribara2020metabolicsyndromeperturbs pages 5-7
sagert2023theerfolding pages 1-2
williams2024insightsintothe pages 3-4
williams2024insightsintothe pages 1-2
kuribara2020metabolicsyndromeperturbs pages 7-9
kuribara2020metabolicsyndromeperturbs pages 9-10
kuribara2020metabolicsyndromeperturbs pages 2-5
adams2020quantitativeglycoproteomicsreveals pages 4-7
williams2024insightsintothe pages 2-3
williams2024insightsintothe pages 4-5
kuribara2020metabolicsyndromeperturbs pages 1-2
https://doi.org/10.7554/eLife.85432
https://doi.org/10.1101/2023.10.18.562958
https://doi.org/10.1073/pnas.2315009121
https://doi.org/10.1111/febs.15330
https://doi.org/10.1002/1873-3468.13780
https://doi.org/10.7554/elife.85432
https://doi.org/10.7554/elife.63997
https://doi.org/10.7554/elife.85432,
https://doi.org/10.7554/elife.63997,
https://doi.org/10.1101/2023.10.18.562958,
https://doi.org/10.1073/pnas.2315009121,
https://doi.org/10.1111/febs.15330,
https://doi.org/10.1002/1873-3468.13780,

📚 Additional Documentation

Bioreason Rl Predictions

(Uggt1-bioreason-rl-predictions.md)

BioReason Chat Export

Exported on March 22, 2026 at 01:05 AM

Organism: Rattus norvegicus

Sequence:

MCSRGDANAAGAAAARRVTGLCYNMGLLIALALLCLFSLAEANSKAITTSLTTKWFSAPLLLEASEFLAEDSQEKFWSFVEASQNIGSSDQHDTDRSYYDAILEAAFRFLSPLQQNLLKFCLSLRSYSASIQAFQQIAVDEPPPEGCKSFLSVHGKQTCDLGTLESLLLTAPDRPKPLLFKGDHRYPSSNPESPVVIFYSEIGHEEFSNIHHQLISKSNEGKINYVFRHYISNPRKEPVHLSGYGVELAIKSTEYKAKDDTQVKGTEVNTTVIGENDPIDEVQGFLFGKLRELYPSLEGQLKEFRKHLVESTNEMAPLKVWQLQDLSFQTAARILAAPVELALVVMKDISQNFPTKARAITKTAVSAQLRAEVEENQKYFKGTIGLQPGDSALFINGLHIDLDTQDIFSLFDTLRNEARVMEGLHRLGIEGLSLHNILKLNIQPSETDYAVDIRSPAISWVNNLEVDSRYNSWPSSLQELLRPTFPGVIRQIRKNLHNMVFIVDPVHETTAELVSIAEMFLSNHIPLRIGFIFVVNDSEDVDGMQDAGVAVLRAYNYVGQEVDGYHAFQTLTQIYNKVRTGEKVKVEHVVSVLEKKYPYVEVNSILGIDSAYDQNRKEARGYYEQTGVGPLPVVLFNGMPFEKEQLDPDELETITMHKILETTTFFQRAVYLGELSHDQDVVEYIMNQPNVVPRINSRILTAKREYLDLTASNNFYVDDFARFSALDSRGKTAAIANSMNYLTKKGMSSKEIYDDSFIRPVTFWIVGDFDSPSGRQLLYDAIKHQKTSNNVRISMINNPSREISDSSTPVSRAIWAALQTQTSNSAKNFITKMVKEETAEALAAGVDIGEFSVGGMDVSLFKEVFESSRMDFILSHALYCRDVLKLKKGQRVVISNGRIIGPLEDSELFNQDDFHLLENIILKTSGQKIKSHIQQLRVEEDVASDLVMKVDALLSAQPKGEARIEYQFFEDKHSAIKLKPKEGETYYDVVAVVDPVTREAQRLAPLLLVLAQLINMSLRVFMNCQSKLSDMPLKSFYRYVLEPEISFTADNSFAKGPIAKFLDMPQSPLFTLNLNTPESWMVESVRTPYDLDNIYLEEVDSIVAAEYELEYLLLEGHCYDITTGQPPRGLQFTLGTSANPTTVDTIVMANLGYFQLKANPGAWILRLRKGRSDDIYRIYSHDGTDSPPDANDVVVILNNFKSKIIKVKVQKKADMANEDLLSDGTNENESGFWDSFKWGFSGQKTEEVKQDKDDIINIFSVASGHLYERFLRIMMLSVLKNTKTPVKFWFLKNYLSPTFKEFIPYMAKKYNFQYELVQYKWPRWLHQQTEKQRIIWGYKILFLDVLFPLVVDKFLFVDADQIVRTDLKELRDFNLDGAPYGYTPFCDSRREMDGYRFWKSGYWASHLAGRKYHISALYVVDLKKFRKIAAGDRLRGQYQGLSQDPNSLSNLDQDLPNNMIHQVPIKSLPQEWLWCETWCDDASKKRAKTIDLCNNPMTKEPKLEAAVRIVPEWQDYDQEIKQLQTLFQEEKELGTLHEEETQEGSQKHEEL

Thinking Trace

I begin with the InterPro architecture. A broad family signature, IPR009448 (UDP-glucose:Glycoprotein Glucosyltransferase family, residues 34–1541), blankets almost the entire polypeptide, establishing identity as a UDP-glucose-dependent glucosyltransferase specialized for glycoprotein quality control. The N-terminal two-thirds are partitioned into three thioredoxin-like folds: IPR040693 (UGGT, thioredoxin-like domain 1, residues 58–236), IPR040694 (thioredoxin-like domain 2, residues 312–443), and IPR040692 (thioredoxin-like domain 3, residues 451–699). A fourth thioredoxin-like module follows: IPR040525 (UDP-glucose:glycoprotein glucosyltransferase, thioredoxin-like domain 4, residues 723–955). These repeated thioredoxin-like domains form a modular recognition platform rather than a redox enzyme; in UGGTs they create a multi-surface scaffold that samples and clamps unfolded or non-native glycoprotein conformers. This modular recognition causes selective binding of denatured substrates and positions them for catalysis.

The C-terminal third houses the catalytic engine: IPR029044 (Nucleotide-diphospho-sugar transferases homologous superfamily, residues 1256–1519) and IPR040497 (Glucosyltransferase 24, catalytic domain, residues 1256–1523). This GT-B–type nucleotide-sugar transferase core binds UDP-glucose and executes glycosyl transfer to exposed hydroxyls on misfolded glycoproteins. The ordered layout—three thioredoxin-like recognition modules leading into a UDP-sugar catalytic domain—explains how the enzyme binds and assesses unfolded substrates and then reglucosylates them.

From these domains, the molecular function resolves as glycosyltransferase chemistry that uses UDP-glucose to add a glucose moiety to glycoprotein substrates, matching GO:0016740 glycosyltransferase activity. The thioredoxin-like array dictates specificity toward non-native conformers, while the GT24 catalytic core performs the sugar transfer that tags glycoproteins for further folding cycles.

This activity feeds directly into biological quality control of secretory-pathway proteins. By reglucosylating non-native glycoproteins, the enzyme sustains the calnexin/calreticulin cycle and thereby enforces ER protein maturation, which is a core facet of GO:0006458 protein folding and, more specifically, glycoprotein quality control in the secretory pathway. The repeated thioredoxin-like modules function as conformational sentinels; their occupancy correlates with folding state, ensuring that only properly folded clients exit the cycle.

Cellular placement follows from function and architecture. The absence of transmembrane domains and the reliance on soluble thioredoxin-like scaffolding indicate a soluble luminal enzyme that operates within the endoplasmic reticulum. This aligns with a residency in the endoplasmic reticulum and supports the GO:0005783 endoplasmic reticulum. A soluble luminal orientation allows continuous surveillance of nascent glycoproteins emerging from ER translocons.

Mechanistically, I hypothesize that the thioredoxin-like domains (residues 58–955) act as a multivalent clamp that captures unfolded glycoproteins and presents them to the C-terminal GT24 catalytic core (residues 1256–1523). Upon binding UDP-glucose, the catalytic domain transfers glucose to specific acceptor hydroxyls on the substrate, re-establishing a recognition epitope that recruits lectin chaperones. This reglucosylation likely occurs adjacent to the calnexin/calreticulin system and transiently couples to ER-resident chaperones and oxidoreductases. Expected partners include calnexin and calreticulin for lectin-mediated retention, ERp57 and other protein disulfide isomerases for oxidative folding, BiP/HSPA5 for general chaperoning, and UDP-glucose–supply pathways that feed the GT-B catalytic module. Together, these interactions create a luminal decision hub that triages folding states and cycles non-native glycoproteins through reglucosylation until they achieve native conformation.

Functional Summary

An endoplasmic reticulum–resident glucosyltransferase that recognizes non-native glycoproteins via a multi-thioredoxin-like recognition platform and uses UDP-glucose to reglucosylate them, thereby feeding substrates back into lectin-assisted folding cycles. By tagging incompletely folded glycoproteins, it sustains quality control and promotes productive maturation within the ER lumen, operating as a soluble luminal catalyst that coordinates with calnexin/calreticulin pathways and associated chaperone systems.

UniProt Summary

Mediates the glucose-dependent regulation of protein folding in the endoplasmic reticulum. It catalyzes the transfer of a glucose moiety from UDP-glucose to non-native glycoproteins thereby assisting their proper folding; similar activity can be exhibited by UGGT2.

InterPro Domains

UDP-glucose:Glycoprotein Glucosyltransferase (IPR009448, family) — residues 34-1541
UGGT, thioredoxin-like domain 1 (IPR040693, domain) — residues 58-236
UGGT, thioredoxin-like domain 2 (IPR040694, domain) — residues 312-443
UGGT, thioredoxin-like domain 3 (IPR040692, domain) — residues 451-699
UDP-glucose:glycoprotein glucosyltransferase, thioredoxin-like domain 4 (IPR040525, domain) — residues 723-955
Nucleotide-diphospho-sugar transferases (IPR029044, homologous_superfamily) — residues 1256-1519
Glucosyltransferase 24, catalytic domain (IPR040497, domain) — residues 1256-1523

GO Terms

Molecular Function: molecular_function (GO:0003674), binding (GO:0005488), catalytic activity (GO:0003824), glycosyltransferase activity (GO:0016740), protein binding (GO:0005515), glycosyltransferase activity (GO:0016757), unfolded protein binding (GO:0051082), hexosyltransferase activity (GO:0016758), UDP-glycosyltransferase activity (GO:0008194), glucosyltransferase activity (GO:0046527), UDP-glucosyltransferase activity (GO:0035251)

Biological Process: biological_process (GO:0008150), cellular process (GO:0009987), protein folding (GO:0006457), protein folding (GO:0006458), 'de novo' post-translational protein folding (GO:0051084)

Cellular Component: cellular_component (GO:0005575), cellular anatomical entity (GO:0110165), intracellular anatomical structure (GO:0005622), organelle (GO:0043226), membrane-enclosed lumen (GO:0031974), cytoplasm (GO:0005737), endomembrane system (GO:0012505), organelle lumen (GO:0043233), endoplasmic reticulum (GO:0005783), intracellular organelle (GO:0043229), membrane-bounded organelle (GO:0043227), endoplasmic reticulum-Golgi intermediate compartment (GO:0005793), endoplasmic reticulum lumen (GO:0005788), intracellular membrane-bounded organelle (GO:0043231), intracellular organelle lumen (GO:0070013)

Generated by BioReason

Bioreason Rl Review

(Uggt1-bioreason-rl-review.md)

BioReason-Pro RL Review: Uggt1 (rat)

Source: Uggt1-bioreason-rl-predictions.md

Correctness: 5/5
Completeness: 5/5

Functional Summary Review

The functional summary states:

An endoplasmic reticulum-resident glucosyltransferase that recognizes non-native glycoproteins via a multi-thioredoxin-like recognition platform and uses UDP-glucose to reglucosylate them, thereby feeding substrates back into lectin-assisted folding cycles. By tagging incompletely folded glycoproteins, it sustains quality control and promotes productive maturation within the ER lumen, operating as a soluble luminal catalyst that coordinates with calnexin/calreticulin pathways and associated chaperone systems.

This is an excellent and comprehensive summary. The curated review confirms UDP-glucose:glycoprotein glucosyltransferase activity (GO:0003980), unfolded protein binding (GO:0051082, though marked as over-annotated in favor of more specific terms), endoplasmic reticulum (GO:0005783), ER lumen (GO:0005788), ERGIC (GO:0005793), UDP-glucosylation (GO:0097359), glycosyltransferase activity (GO:0016757), and protein folding (GO:0006457).

BioReason accurately describes the four thioredoxin-like recognition domains as "conformational sentinels" that assess folding state -- this is a correct and informative interpretation of the domain architecture. The GT24 catalytic domain description and UDP-glucose utilization are accurate.

The mechanistic description of the calnexin/calreticulin cycle, the reglucosylation-based quality control loop, and the coordination with ERp57/PDI and BiP/HSPA5 is all well-supported by established ER biology. The summary captures both the molecular mechanism and its biological context comprehensively.

Notably, the curated review marks unfolded protein binding (GO:0051082) as over-annotated, preferring more specific terms. BioReason's thinking trace describes the thioredoxin-like domains as recognizing "non-native conformers" -- which aligns with the biology without over-committing to the generic GO term.

Comparison with interpro2go:

The interpro2go annotation for Uggt1 is glycoprotein biosynthetic process (GO:0009101), which the curated review keeps as non-core. BioReason does not recapitulate this annotation directly but instead correctly focuses on the quality control / reglucosylation role rather than biosynthesis per se. This is a more accurate representation -- Uggt1 is not involved in de novo glycoprotein synthesis but rather in folding quality control via the calnexin/calreticulin cycle. BioReason provides significantly more insight than interpro2go here.

Notes on thinking trace

The trace is among the best in this set. The domain-by-domain walkthrough is thorough, and the functional interpretation is precise. The distinction between the thioredoxin-like domains serving as recognition platforms (not redox enzymes) is explicitly stated and correct. The hypothesized interaction with BiP/HSPA5, calnexin/calreticulin, ERp57, and UDP-glucose supply pathways is well-supported. The characterization of the enzyme as a "luminal decision hub" is an apt description.

📄 View Raw YAML

id: Q9JLA3
gene_symbol: Uggt1
product_type: PROTEIN
status: DRAFT
taxon:
  id: NCBITaxon:10116
  label: Rattus norvegicus
description: >-
  Uggt1 (UGGT1; UniProt Q9JLA3) encodes the rat UDP-glucose:glycoprotein
  glucosyltransferase 1, a ~170 kDa endoplasmic reticulum (ER) luminal
  glycoprotein-folding sensor and quality-control enzyme. It transfers a single
  glucose residue from UDP-glucose onto deglucosylated N-linked glycans
  (Man7-9GlcNAc2; e.g. Man9GlcNAc2 -> Glc1Man9GlcNAc2) on glycoproteins that have
  not reached a native conformation. This reglucosylation regenerates the
  monoglucosylated tag recognized by the lectin chaperones calnexin/calreticulin,
  driving the calnexin/calreticulin (CNX/CRT) folding cycle: non-native clients
  are retained for further folding attempts and prevented from premature ER exit.
  UGGT1 acts as a conformation sensor, preferentially recognizing non-native
  glycoproteins with exposed hydrophobic surfaces, and it can delay entry of
  unstable/misfolded clients into glycoprotein ER-associated degradation (gpERAD),
  competing with EDEM/mannose-trimming pathways. Catalysis requires Ca2+
  coordinated by a DxD motif. UGGT1 is the dominant cellular glucosyltransferase
  of this system and forms a stable complex with the selenoprotein SELENOF (SEP15),
  a redox-active cochaperone.
existing_annotations:
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: This is the defining core molecular function of UGGT1. It transfers a
      glucose residue from UDP-glucose onto deglucosylated N-linked glycans on
      non-native glycoproteins, regenerating the monoglucosylated tag of the
      calnexin/calreticulin cycle. Falcon deep research confirms the reaction and
      its Ca2+/DxD-motif requirement.
    action: ACCEPT
    reason: Core molecular function, well supported phylogenetically (IBA), by direct
      rat biochemistry (PMID:10764828, PMID:1533626), and by the falcon synthesis.
    additional_reference_ids:
    - file:rat/Uggt1/Uggt1-deep-research-falcon.md
    supported_by:
    - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
      supporting_text: |-
        UGGT1 is a **reglucosylating glycosyltransferase** that transfers a **glucose residue from UDP-glucose** onto **deglucosylated N-linked glycans** on glycoproteins that have not reached a native conformation.
      reference_section_type: OTHER
    - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
      supporting_text: |-
        UGGT1 converted **Man9GlcNAc2 → Glc1Man9GlcNAc2** on MHC I, which is the canonical “tag” for lectin-chaperone binding in the ER.
      reference_section_type: OTHER
    - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
      supporting_text: |-
        UGGT1 catalytic activity requires **Ca2+**, coordinated by a **DxD motif** in the catalytic site
      reference_section_type: OTHER
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: 'Manual review: endoplasmic reticulum is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0051082
    label: unfolded protein binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: UGGT1 is a conformation sensor that selectively recognizes and binds
      non-native/partially folded glycoproteins (preferring exposed hydrophobic
      surfaces) as the recognition step preceding reglucosylation. This is a genuine
      core molecular function, not an over-annotation; the falcon synthesis supports
      it directly and the binding activity is also documented by direct assay
      (GO:0051082 IDA from PMID:10764828).
    action: ACCEPT
    reason: Reversed prior over-annotation call. Recognition/binding of non-native
      glycoprotein clients is the substrate-selection function intrinsic to UGGT1's
      folding-sensor role, supported by IBA, IDA, and the falcon synthesis.
    additional_reference_ids:
    - file:rat/Uggt1/Uggt1-deep-research-falcon.md
    supported_by:
    - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
      supporting_text: |-
        UGGT1 is a conformation sensor: it preferentially acts on proteins that are **non-native** and can prefer clients with **exposed hydrophobic regions**, consistent with recognition of misfolded/partially folded surfaces rather than fully folded proteins.
      reference_section_type: OTHER
- term:
    id: GO:0097359
    label: UDP-glucosylation
  evidence_type: IEA
  original_reference_id: GO_REF:0000108
  review:
    summary: 'Manual review: UDP-glucosylation is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: 'Manual review: UDP-glucose:glycoprotein glucosyltransferase activity is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0005788
    label: endoplasmic reticulum lumen
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: 'Manual review: endoplasmic reticulum lumen is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0005793
    label: endoplasmic reticulum-Golgi intermediate compartment
  evidence_type: IEA
  original_reference_id: GO_REF:0000044
  review:
    summary: 'Manual review: endoplasmic reticulum-Golgi intermediate compartment is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0009101
    label: glycoprotein biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: 'Manual review: glycoprotein biosynthetic process may be context-dependent or peripheral for Uggt1.'
    action: KEEP_AS_NON_CORE
    reason: Kept as non-core to preserve potentially valid context-specific annotation without elevating it to core function.
- term:
    id: GO:0016740
    label: transferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: 'Manual review: transferase activity is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0016757
    label: glycosyltransferase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: 'Manual review: glycosyltransferase activity is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:1901135
    label: carbohydrate derivative metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: 'Manual review: carbohydrate derivative metabolic process may be context-dependent or peripheral for Uggt1.'
    action: KEEP_AS_NON_CORE
    reason: Kept as non-core to preserve potentially valid context-specific annotation without elevating it to core function.
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: ISO
  original_reference_id: GO_REF:0000121
  review:
    summary: 'Manual review: UDP-glucose:glycoprotein glucosyltransferase activity is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0009306
    label: protein secretion
  evidence_type: ISO
  original_reference_id: GO_REF:0000121
  review:
    summary: 'Manual review: protein secretion may be context-dependent or peripheral for Uggt1.'
    action: KEEP_AS_NON_CORE
    reason: Kept as non-core to preserve potentially valid context-specific annotation without elevating it to core function.
- term:
    id: GO:0032991
    label: protein-containing complex
  evidence_type: ISO
  original_reference_id: GO_REF:0000121
  review:
    summary: 'Manual review: protein-containing complex may be context-dependent or peripheral for Uggt1.'
    action: KEEP_AS_NON_CORE
    reason: Kept as non-core to preserve potentially valid context-specific annotation without elevating it to core function.
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:11278576
  review:
    summary: This IPI corresponds to the specific UGGT1-SELENOF (SEP15) interaction
      reported in PMID:11278576. The bare 'protein binding' term is uninformative;
      the functionally relevant partnership is a stable, high-affinity complex with
      the redox-active selenoprotein cochaperone SELENOF, documented in the falcon
      synthesis. The interaction itself is real and biologically meaningful, but
      GO:0005515 does not capture it.
    action: MARK_AS_OVER_ANNOTATED
    reason: Bare protein binding is uninformative per curation guidelines. The
      underlying SELENOF/SEP15 interaction is captured descriptively here rather
      than by this generic term.
    additional_reference_ids:
    - file:rat/Uggt1/Uggt1-deep-research-falcon.md
    supported_by:
    - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
      supporting_text: |-
        UGGT1 forms a stable complex with the selenoprotein **SEP15/SELENOF**, which is proposed to act as a **redox-active cochaperone** in ER folding surveillance.
      reference_section_type: OTHER
- term:
    id: GO:0005788
    label: endoplasmic reticulum lumen
  evidence_type: IDA
  original_reference_id: PMID:11535823
  review:
    summary: UGGT1 is a soluble ER luminal enzyme bearing a C-terminal ER-retention
      motif; the ER lumen is where it carries out reglucosylation as part of the
      CNX/CRT quality-control cycle. This is the core site of action, supported by
      direct immunolocalization (PMID:11535823) and the falcon synthesis.
    action: ACCEPT
    reason: Core subcellular localization, directly observed (IDA) and consistent
      with the falcon synthesis describing UGGT1 as an ER-resident luminal enzyme.
    additional_reference_ids:
    - file:rat/Uggt1/Uggt1-deep-research-falcon.md
    supported_by:
    - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
      supporting_text: |-
        UGGT1 is described across multiple mammalian studies as **ER-localized/ER-resident** and operating in the **ER lumen** as part of ER protein quality control and early secretory pathway surveillance.
      reference_section_type: OTHER
- term:
    id: GO:0005793
    label: endoplasmic reticulum-Golgi intermediate compartment
  evidence_type: IDA
  original_reference_id: PMID:11535823
  review:
    summary: 'Manual review: endoplasmic reticulum-Golgi intermediate compartment is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0051082
    label: unfolded protein binding
  evidence_type: ISO
  original_reference_id: GO_REF:0000121
  review:
    summary: Same as the IBA/IDA unfolded protein binding annotations - recognition
      and binding of non-native glycoprotein clients is a core UGGT1 function, not
      an over-annotation. The ISO transfer from orthologs is consistent with the
      conserved folding-sensor mechanism described in the falcon synthesis.
    action: ACCEPT
    reason: Reversed prior over-annotation call to match the IDA-supported core
      recognition function of UGGT1.
    additional_reference_ids:
    - file:rat/Uggt1/Uggt1-deep-research-falcon.md
    supported_by:
    - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
      supporting_text: |-
        UGGT1 preferentially acts on **non-native/partially folded glycoproteins** and prefers proteins with **exposed hydrophobic regions** over folded proteins.
      reference_section_type: OTHER
- term:
    id: GO:0051082
    label: unfolded protein binding
  evidence_type: IDA
  original_reference_id: PMID:10764828
  review:
    summary: Direct-assay evidence that UGGT1 binds non-native protein substrates.
      Recognition of misfolded/partially folded glycoproteins is the substrate-selection
      step of the folding-sensor mechanism and is a core molecular function. Reversing
      the prior over-annotation call; the falcon synthesis corroborates the
      conformation-sensing recognition activity.
    action: ACCEPT
    reason: Direct experimental evidence (IDA) for binding of non-native protein
      clients; this is the core recognition function of UGGT1, not generic protein
      binding.
    additional_reference_ids:
    - file:rat/Uggt1/Uggt1-deep-research-falcon.md
    supported_by:
    - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
      supporting_text: |-
        UGGT1 is a conformation sensor: it preferentially acts on proteins that are **non-native** and can prefer clients with **exposed hydrophobic regions**
      reference_section_type: OTHER
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:10764828
  review:
    summary: 'Manual review: protein binding is too generic or over-extended for Uggt1.'
    action: MARK_AS_OVER_ANNOTATED
    reason: Marked over-annotated because more specific terms capture the biology more accurately.
- term:
    id: GO:0005783
    label: endoplasmic reticulum
  evidence_type: ISO
  original_reference_id: GO_REF:0000121
  review:
    summary: 'Manual review: endoplasmic reticulum is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:10764828
  review:
    summary: 'Manual review: UDP-glucose:glycoprotein glucosyltransferase activity is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0051084
    label: '''de novo'' post-translational protein folding'
  evidence_type: TAS
  original_reference_id: PMID:10764828
  review:
    summary: 'Manual review: ''de novo'' post-translational protein folding may be context-dependent or peripheral for Uggt1.'
    action: KEEP_AS_NON_CORE
    reason: Kept as non-core to preserve potentially valid context-specific annotation without elevating it to core function.
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: TAS
  original_reference_id: PMID:10764828
  review:
    summary: 'Manual review: UDP-glucose:glycoprotein glucosyltransferase activity is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  evidence_type: IDA
  original_reference_id: PMID:12518055
  review:
    summary: 'Manual review: UDP-glucose:glycoprotein glucosyltransferase activity is consistent with known biology of Uggt1.'
    action: ACCEPT
    reason: Retained as supported or plausible for this gene and evidence context.
- term:
    id: GO:0006457
    label: protein folding
  evidence_type: TAS
  original_reference_id: PMID:12518055
  review:
    summary: UGGT1 contributes to protein folding indirectly, by reglucosylating
      non-native glycoproteins so they re-engage the calnexin/calreticulin lectin
      chaperones for additional folding rounds and avoid premature ER exit. The
      generic 'protein folding' term captures this only at a high level; the precise
      role is the glycan-dependent quality-control/folding cycle described in the
      falcon synthesis. Retained as a valid but non-core/broad annotation.
    action: KEEP_AS_NON_CORE
    reason: UGGT1 does not directly fold proteins; it drives the lectin-chaperone
      folding cycle. Kept as non-core because the term is broad relative to the
      specific reglucosylation/quality-control mechanism.
    additional_reference_ids:
    - file:rat/Uggt1/Uggt1-deep-research-falcon.md
    supported_by:
    - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
      supporting_text: |-
        When a glycoprotein carries a **monoglucosylated N-glycan** it can bind CNX/CRT; after deglucosylation, a protein that is still non-native can be **reglucosylated by UGGT1**, enabling additional rounds of CNX/CRT-assisted folding and preventing premature ER exit.
      reference_section_type: OTHER
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000044
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location vocabulary mapping, accompanied by conservative changes to GO terms applied by UniProt
  findings: []
- id: GO_REF:0000108
  title: Automatic assignment of GO terms using logical inference, based on on inter-ontology links
  findings: []
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: GO_REF:0000121
  title: RGD ISO annotations to rat from other mammalian species
  findings: []
- id: PMID:10764828
  title: 'Cloning and characterization of mammalian UDP-glucose glycoprotein: glucosyltransferase and the development of a specific substrate for this enzyme.'
  findings: []
- id: PMID:11278576
  title: Association between the 15-kDa selenoprotein and UDP-glucose:glycoprotein glucosyltransferase in the endoplasmic reticulum of mammalian cells.
  findings: []
- id: PMID:11535823
  title: Immunolocalization of UDP-glucose:glycoprotein glucosyltransferase indicates involvement of pre-Golgi intermediates in protein quality control.
  findings: []
- id: PMID:12518055
  title: UDP-Glc:glycoprotein glucosyltransferase recognizes structured and solvent accessible hydrophobic patches in molten globule-like folding intermediates.
  findings: []
- id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
  title: 'Falcon (Edison Scientific) deep research report: Functional Annotation of
    Rat Uggt1 (UGGT1; UniProt Q9JLA3)'
  findings:
  - statement: UGGT1 is an ER luminal glycoprotein-folding sensor that reglucosylates
      N-linked glycans on non-native glycoproteins, acting as the central quality-control
      enzyme of the calnexin/calreticulin cycle.
    supporting_text: |-
      a ~170 kDa **endoplasmic reticulum (ER) luminal** glycoprotein-folding sensor and quality-control enzyme that catalyzes reglucosylation of N-linked glycans on non-native glycoproteins.
    reference_section_type: OTHER
  - statement: UGGT1 transfers glucose from UDP-glucose onto deglucosylated N-glycans,
      converting Man9GlcNAc2 to Glc1Man9GlcNAc2, the tag recognized by lectin
      chaperones.
    supporting_text: |-
      UGGT1 converted **Man9GlcNAc2 → Glc1Man9GlcNAc2** on MHC I, which is the canonical “tag” for lectin-chaperone binding in the ER.
    reference_section_type: OTHER
  - statement: Catalysis requires Ca2+ coordinated by a DxD motif in the catalytic
      site.
    supporting_text: |-
      UGGT1 catalytic activity requires **Ca2+**, coordinated by a **DxD motif** in the catalytic site
    reference_section_type: OTHER
  - statement: UGGT1 is a conformation sensor that preferentially recognizes non-native
      glycoproteins with exposed hydrophobic regions.
    supporting_text: |-
      UGGT1 is a conformation sensor: it preferentially acts on proteins that are **non-native** and can prefer clients with **exposed hydrophobic regions**, consistent with recognition of misfolded/partially folded surfaces rather than fully folded proteins.
    reference_section_type: OTHER
  - statement: UGGT1 functions within the calnexin/calreticulin (CNX/CRT) cycle,
      reglucosylating misfolded glycoproteins so they rebind lectin chaperones and
      avoid premature ER exit.
    supporting_text: |-
      UGGT1’s primary pathway role is within the **N-glycan-dependent lectin chaperone system** (CNX/CRT cycle) that retains and refolds non-native glycoproteins.
    reference_section_type: OTHER
  - statement: UGGT1-mediated reglucosylation can delay entry into glycoprotein ERAD,
      competing with EDEM/mannose-trimming degradation pathways in a tug-of-war over
      glycoprotein fate.
    supporting_text: |-
      UGGT1-mediated reglucosylation can **delay entry into gpERAD**, competing with EDEM/mannose trimming that promotes degradation.
    reference_section_type: OTHER
  - statement: UGGT1 is the dominant cellular glucosyltransferase of this system and
      shows preference toward large plasma-membrane proteins.
    supporting_text: |-
      UGGT1 was the **dominant** cellular glucosyltransferase in that study and showed preference toward **large plasma-membrane proteins**, while UGGT2 favored smaller soluble lysosomal proteins
    reference_section_type: OTHER
  - statement: UGGT1 forms a stable complex with the selenoprotein SELENOF (SEP15),
      a proposed redox-active cochaperone.
    supporting_text: |-
      UGGT1 forms a stable complex with the selenoprotein **SEP15/SELENOF**, which is proposed to act as a **redox-active cochaperone** in ER folding surveillance.
    reference_section_type: OTHER
  - statement: UGGT1 is an ER-resident luminal enzyme of the early secretory pathway.
    supporting_text: |-
      UGGT1 is described across multiple mammalian studies as **ER-localized/ER-resident** and operating in the **ER lumen** as part of ER protein quality control and early secretory pathway surveillance.
    reference_section_type: OTHER
  - statement: UGGT1 is widely conceptualized as an ER gatekeeper / folding sensor
      that enforces quality control of the secretory proteome via glycan
      reglucosylation.
    supporting_text: |-
      UGGT1 is widely conceptualized as an ER “**gatekeeper**” or “folding sensor” that enforces quality control of the secretory proteome via glycan reglucosylation
    reference_section_type: OTHER
core_functions:
- description: ER luminal folding sensor that reglucosylates non-native glycoproteins
    to regenerate the monoglucosylated N-glycan tag, driving the calnexin/calreticulin
    quality-control cycle.
  supported_by:
  - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
    supporting_text: |-
      UGGT1 is a **reglucosylating glycosyltransferase** that transfers a **glucose residue from UDP-glucose** onto **deglucosylated N-linked glycans** on glycoproteins that have not reached a native conformation.
    reference_section_type: OTHER
  molecular_function:
    id: GO:0003980
    label: UDP-glucose:glycoprotein glucosyltransferase activity
  directly_involved_in:
  - id: GO:0006457
    label: protein folding
  locations:
  - id: GO:0005788
    label: endoplasmic reticulum lumen
- description: Conformation-sensing recognition and binding of non-native/partially
    folded glycoprotein clients (the substrate-selection step preceding reglucosylation).
  supported_by:
  - reference_id: file:rat/Uggt1/Uggt1-deep-research-falcon.md
    supporting_text: |-
      UGGT1 is a conformation sensor: it preferentially acts on proteins that are **non-native** and can prefer clients with **exposed hydrophobic regions**, consistent with recognition of misfolded/partially folded surfaces rather than fully folded proteins.
    reference_section_type: OTHER
  molecular_function:
    id: GO:0051082
    label: unfolded protein binding
  locations:
  - id: GO:0005788
    label: endoplasmic reticulum lumen
suggested_questions:
- question: Does rat UGGT1 reglucosylation actively delay glycoprotein ERAD in vivo,
    and how is the balance between refolding and degradation set in rat tissues?
- question: Is the UGGT1-SELENOF (SEP15) complex required for full reglucosylation
    activity or substrate selectivity in rat liver ER, where UGGT1 was first purified?
suggested_experiments:
- description: Measure rat UGGT1 reglucosylation activity on defined non-native glycoprotein
    substrates (e.g. M9-BODIPY) in liver ER fractions with and without Ca2+ chelation
    and DxD-motif mutation, to dissociate client binding from catalysis.
- description: Use SELENOF/SEP15 knockdown in a rat hepatocyte model to test whether
    loss of the cochaperone alters the set of glycoproteins reglucosylated by UGGT1
    and shifts client fate toward gpERAD.

Uggt1

Gene Description

Existing Annotations Review

Core Functions

ER luminal folding sensor that reglucosylates non-native glycoproteins to regenerate the monoglucosylated N-glycan tag, driving the calnexin/calreticulin quality-control cycle.

Conformation-sensing recognition and binding of non-native/partially folded glycoprotein clients (the substrate-selection step preceding reglucosylation).

References

Suggested Questions for Experts

Suggested Experiments

Deep Research

Falcon

Research Report: Functional Annotation of Rat Uggt1 (UGGT1; UniProt Q9JLA3)

1. Target verification and gene/protein identity (critical disambiguation)

2. Key concepts and definitions (current understanding)

2.1. What reaction does UGGT1 catalyze?

2.2. What is the “calnexin/calreticulin cycle” and UGGT1’s role?

2.3. Substrate specificity (“folding sensor” concept)

3. Recent developments and latest research (prioritizing 2023–2024)

3.1. 2023: UGGT1 cooperates with TAPBPR to enforce MHC I quality control

3.2. 2024: UGGT1 activity competes with ERAD (“tug-of-war” model) and impacts ATF6α signaling

3.3. 2024: Structural/mechanistic insight into the UGGT1–SEP15 (SELENOF) cochaperone complex

4. Cellular localization and pathways

4.1. Subcellular localization

4.2. Primary pathway membership and network context

5. Rat-specific evidence (Rattus norvegicus) for Uggt1 regulation and function

6. Current applications and real-world implementations

7. Expert opinion and authoritative synthesis (with grounded interpretation)

8. Summary of key evidence (quick reference)

9. Limitations of the current evidence base for rat Uggt1

Artifacts

Citations

📚 Additional Documentation

Bioreason Rl Predictions

BioReason Chat Export

Thinking Trace

Functional Summary

UniProt Summary

InterPro Domains

GO Terms

Bioreason Rl Review

BioReason-Pro RL Review: Uggt1 (rat)

Functional Summary Review

Notes on thinking trace

📄 View Raw YAML